{"ModuleTitle": "Company Description", "CompanyName": "Cerus Corporation", "Symbol": "CERS", "Address": "1220 CONCORD AVENUE SUITE 600, CONCORD, California, 94520, United States of America", "Phone": "9252886000", "Industry": "Medical/Dental Instruments", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a biomedical products company focused on developing and commercializing\r\nthe INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System,\r\nwhich is based on our proprietary technology for controlling biological\r\nreplication, is designed to reduce blood-borne pathogens in donated blood\r\ncomponents intended for transfusion.\r\n\r\nOur INTERCEPT Blood System is for use with three blood components: plasma,\r\nplatelets, and red blood cells. The INTERCEPT Blood System for platelets, or\r\nplatelet system, and the INTERCEPT Blood System for plasma, or plasma system,\r\nhave received a broad range of regulatory approvals, including but not limited\r\nto U.S.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f21%2f0001564590-20-005756.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Carol M. Moore", "title": "Senior VP-Regulatory Affairs, Quality & Clinical"}, {"name": "Kevin Dennis Green", "title": "Chief Financial Officer & Vice President-Finance"}, {"name": "Laurence M. Corash", "title": "Chief Scientific Officer"}, {"name": "Richard J. Benjamin", "title": "Chief Medical Officer"}, {"name": "Vivek K. Jayaraman", "title": "Chief Operating Officer"}, {"name": "William Mariner Greenman", "title": "President, Chief Executive Officer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}